Similar articles for PMID: 31978780

Year	Number of Results
2002	1
2006	1
2007	3
2009	1
2010	2
2011	2
2012	1
2013	2
2014	5
2015	12
2016	9
2017	12
2018	16
2019	15
2020	5
2021	2
2024	0

1

Efficient identification of novel anti-glioma lead compounds by machine learning models.

Neves BJ, Agnes JP, Gomes MDN, Henriques Donza MR, Gonçalves RM, Delgobo M, Ribeiro de Souza Neto L, Senger MR, Silva-Junior FP, Ferreira SB, Zanotto-Filho A, Andrade CH. Neves BJ, et al. Eur J Med Chem. 2020 Mar 1;189:111981. doi: 10.1016/j.ejmech.2019.111981. Epub 2019 Dec 19. Eur J Med Chem. 2020. PMID: 31978780

2

NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.

Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G. Yu Z, et al. Cancer Lett. 2015 Oct 10;367(1):58-68. doi: 10.1016/j.canlet.2015.07.007. Epub 2015 Jul 15. Cancer Lett. 2015. PMID: 26188279

3

Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.

Koul D, Wang S, Wu S, Saito N, Zheng S, Gao F, Kaul I, Setoguchi M, Nakayama K, Koyama K, Shiose Y, Sulman EP, Hirota Y, Yung WKA. Koul D, et al. Oncotarget. 2017 Mar 28;8(13):21741-21753. doi: 10.18632/oncotarget.15566. Oncotarget. 2017. PMID: 28423515 Free PMC article.

4

β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.

Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G. Bi Y, et al. Cancer Lett. 2018 Oct 28;435:66-79. doi: 10.1016/j.canlet.2018.07.040. Epub 2018 Aug 4. Cancer Lett. 2018. PMID: 30081068

5

FK228 augmented temozolomide sensitivity in human glioma cells by blocking PI3K/AKT/mTOR signal pathways.

Wu Y, Dong L, Bao S, Wang M, Yun Y, Zhu R. Wu Y, et al. Biomed Pharmacother. 2016 Dec;84:462-469. doi: 10.1016/j.biopha.2016.09.051. Epub 2016 Sep 28. Biomed Pharmacother. 2016. PMID: 27685789

6

The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts.

Adhikari B, Li J, Brandel MG, Futalan D, Akers J, Deming T, Chen CC, Carter BS. Adhikari B, et al. J Clin Neurosci. 2017 Nov;45:288-292. doi: 10.1016/j.jocn.2017.07.027. Epub 2017 Sep 1. J Clin Neurosci. 2017. PMID: 28867360

7

Antitumor activity of a polypyridyl chelating ligand: in vitro and in vivo inhibition of glioma.

David CN, Frias ES, Elix CC, McGovern KE, Walker AM, Eichler JF, Wilson EH. David CN, et al. ASN Neuro. 2015 Jan-Feb;7(1):1759091415572365. doi: 10.1177/1759091415572365. ASN Neuro. 2015. PMID: 25732707 Free PMC article.

8

DMC is not better than TMZ on intracranial anti-glioma effects.

Shi L, Sun G. Shi L, et al. J Cell Biochem. 2018 Jul;119(7):6057-6064. doi: 10.1002/jcb.26803. Epub 2018 Mar 25. J Cell Biochem. 2018. PMID: 29575236

9

Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors.

Golden EB, Cho HY, Hofman FM, Louie SG, Schönthal AH, Chen TC. Golden EB, et al. Neurosurg Focus. 2015 Mar;38(3):E12. doi: 10.3171/2014.12.FOCUS14748. Neurosurg Focus. 2015. PMID: 25727221

10

Cordycepin Augments the Chemosensitivity of Human Glioma Cells to Temozolomide by Activating AMPK and Inhibiting the AKT Signaling Pathway.

Bi Y, Li H, Yi D, Sun Y, Bai Y, Zhong S, Song Y, Zhao G, Chen Y. Bi Y, et al. Mol Pharm. 2018 Nov 5;15(11):4912-4925. doi: 10.1021/acs.molpharmaceut.8b00551. Epub 2018 Oct 17. Mol Pharm. 2018. PMID: 30336060

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

77 results

Results by year